Last reviewed · How we verify
NCT03095391
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™
trial testing VFI in Kidney Diseases in 32 participants. Completed in 20 September 2017.
20 September 2017
Quick facts
| Lead sponsor | FAST BioMedical |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 32 |
| Start date | 13 June 2017 |
| Primary completion | 20 September 2017 |
| Estimated completion | 20 September 2017 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- VFI
- Iohexol (IOHEXOL) — full drug profile →
Conditions studied
- Kidney Diseases — all drugs for Kidney Diseases →
- Renal Insufficiency, Chronic — all drugs for Renal Insufficiency, Chronic →
- Acute Kidney Injury — all drugs for Acute Kidney Injury →
- Urologic Diseases — all drugs for Urologic Diseases →
Sponsor
FAST BioMedical
Who can join
Adults 18 to 75, any sex, with Kidney Diseases or Renal Insufficiency, Chronic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a Phase 2b, prospective, open-label study designed to evaluate the safety, tolerability, PK, and PD of FAST PV and mGFR Technology in healthy subjects and patients with varying degrees of renal impairment.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A Novel Method for Rapid Bedside Measurement of GFR.
Rizk DV, Meier D, Sandoval RM, Chacana T, et al · · 2018 · cited 45× · PMID 29748326 · DOI 10.1681/asn.2018020160 -
A Novel Fluorescent Clinical Method to Rapidly Quantify Plasma Volume.
Molitoris BA, George AG, Murray PT, Meier D, et al · · 2019 · cited 5× · PMID 30844821 · DOI 10.1159/000496480
Verify or expand the search:
- PubMed search for NCT03095391
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of VFI
Trials testing the same drug.
- NCT03808948 — FAST PV and mGFR™ Technology in Congestive Heart Failure · NA · completed
Other recruiting trials for Kidney Diseases
Currently open trials in the same condition.
- NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting
- NCT07217535 — Rutgers University Study of the Genetics of Kidney Disease · recruiting
- NCT06858319 — Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. · Phase 3 · recruiting
- NCT06798909 — Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients · Phase 3 · recruiting
- NCT06759077 — Cardio Protective Effect of SGL2I in Hemodialysis Patients and Its Impact on Patient Quality of Life · Phase 3 · active not recruiting
Other FAST BioMedical trials
Trials by the same sponsor.
- NCT04733664 — Pilot Study to Evaluate Safety, Tolerability, and Performance of the FAST PV Technology™ in Chronic Dialysis Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03095391 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by FAST BioMedical
- Last refreshed: 26 December 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03095391.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing